Biofrontera (BFRI) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…

Biofrontera (BFRI) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: April 25, 2025 (00:06)

Sector: Healthcare

The share price of Biofrontera Inc. (BFRI) now

Latest session on the 24th of April for
Biofrontera Inc. is positive
Trading Volume: 404103
Open: 0.82 /  High: 0.87 /  Low: 0.812
Current value: $0.829
What analysts predict: $10.5
52-week High/Low: $2.13 / $0.651
50-Day Moving Average: $0.94 — resistance level today
200-Day Moving Average: $1.024 — resistance level today

Are you interested in Biofrontera Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biofrontera stock price in 2025, 2026, 2027. How much will one Biofrontera share be worth in 2025 - 2027?

When should I take profit in Biofrontera stock? When should I record a loss on Biofrontera stock? What are analysts' forecasts for Biofrontera stock? What is the future of Biofrontera stock? We forecast Biofrontera stock performance using neural networks based on historical data on Biofrontera stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biofrontera stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biofrontera shares. This happens once a day.


Historical and forecast chart of Biofrontera stock

The chart below shows the historical price of Biofrontera stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biofrontera stock price can be found in the table below.

Long-term forecasts by years.

Biofrontera AG is a German biopharmaceutical company. The company develops medicines and medicinal cosmetics for the treatment of skin diseases and regenerative care for damaged skin. His portfolio includes: Ameluz, a photodynamic therapy (PDT) for actinic keratoses in development for other types of skin cancer and warts; BF-RhodoLED PDT lamp, used after treatment with Ameluz to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itchy, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The company is also in the clinical development of two candidate drugs: BF-derm1, a tablet with an inhibitor that blocks the synthesis of histamine in cells, which causes allergic reactions, and BF1, a selective serotonin receptor for the prevention of migraine. The company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MMF.

Trending Themes in the Healthcare Sector

Biofrontera daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 26 0.88 0.81 0.90 10.80
Apr 27 0.87 0.82 0.90 9.70
Apr 28 0.80 0.79 0.82 4.50
Apr 29 0.74 0.69 0.76 11.03
Apr 30 0.74 0.71 0.78 8.80
May 01 0.71 0.69 0.75 8.53
May 02 0.70 0.68 0.75 9.63
May 03 0.68 0.64 0.73 14.29
May 04 0.72 0.69 0.76 10.53
May 05 0.76 0.71 0.82 15.61
May 06 0.73 0.67 0.77 14.69
May 07 0.78 0.76 0.81 6.76
May 08 0.80 0.74 0.86 16.36
May 09 0.86 0.83 0.92 9.88
May 10 0.88 0.87 0.91 5.00
May 11 0.96 0.93 0.99 6.75
May 12 0.96 0.89 1.04 16.63
May 13 0.92 0.88 0.96 8.87
May 14 0.83 0.81 0.87 7.52
May 15 0.86 0.83 0.93 11.83
May 16 0.89 0.85 0.96 13.58
May 17 0.82 0.77 0.86 11.95
May 18 0.79 0.77 0.83 7.25
May 19 0.80 0.76 0.82 8.24
May 20 0.85 0.82 0.91 11.31
May 21 0.87 0.84 0.91 7.92
May 22 0.80 0.78 0.83 6.46
May 23 0.78 0.72 0.81 12.88
May 24 0.76 0.72 0.80 11.78
May 25 0.72 0.70 0.77 9.94

Biofrontera Daily Price Targets


Biofrontera Stock Forecast 04-26-2025.

Forecast target price for 04-26-2025: $0.88.
Positive dynamics for Biofrontera shares will prevail with possible volatility of 9.747%.
Pessimistic target level: 0.81
Optimistic target level: 0.90

Biofrontera Stock Forecast 04-27-2025.

Forecast target price for 04-27-2025: $0.87.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 8.844%.
Pessimistic target level: 0.82
Optimistic target level: 0.90

Biofrontera Stock Forecast 04-28-2025.

Forecast target price for 04-28-2025: $0.80.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 4.305%.
Pessimistic target level: 0.79
Optimistic target level: 0.82

Biofrontera Stock Forecast 04-29-2025.

Forecast target price for 04-29-2025: $0.74.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 9.932%.
Pessimistic target level: 0.69
Optimistic target level: 0.76

Biofrontera Stock Forecast 04-30-2025.

Forecast target price for 04-30-2025: $0.74.
Positive dynamics for Biofrontera shares will prevail with possible volatility of 8.088%.
Pessimistic target level: 0.71
Optimistic target level: 0.78

Biofrontera Stock Forecast 05-01-2025.

Forecast target price for 05-01-2025: $0.71.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 7.860%.
Pessimistic target level: 0.69
Optimistic target level: 0.75

BFRI (BFRI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
May. 0.94 0.77 1.13 31.59
Jun. 0.89 0.77 0.97 21.23
Jul. 1.01 0.88 1.22 27.77
Aug. 0.71 0.52 0.88 40.66
Sep. 0.81 0.67 1.02 33.66
Oct. 0.67 0.58 0.90 35.21
Nov. 0.82 0.72 0.95 23.90
Dec. 0.78 0.60 1.02 41.01

Biofrontera forecast for this year


Biofrontera Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $0.93568. Pessimistic: $0.77. Optimistic: $1.13


Biofrontera Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $0.892452. Pessimistic: $0.77. Optimistic: $0.97


Biofrontera Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $1.00865. Pessimistic: $0.88. Optimistic: $1.22


Biofrontera Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $0.70787. Pessimistic: $0.52. Optimistic: $0.88


Biofrontera Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $0.8149. Pessimistic: $0.67. Optimistic: $1.02


Biofrontera Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $0.671151. Pessimistic: $0.58. Optimistic: $0.90


Biofrontera Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $0.82055. Pessimistic: $0.72. Optimistic: $0.95


Biofrontera Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $0.775748. Pessimistic: $0.60. Optimistic: $1.02



Biofrontera (BFRI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.88 0.74 1.06 30.41
Feb 0.63 0.47 0.82 43.53
Mar 0.76 0.70 0.88 21.01
Apr 0.70 0.53 0.92 42.48
May 0.57 0.41 0.66 38.17
Jun 0.48 0.34 0.53 35.51
Jul 0.61 0.48 0.81 40.31
Aug 0.58 0.49 0.76 35.15
Sep 0.68 0.60 0.84 28.56
Oct 0.78 0.63 0.92 31.06
Nov 0.86 0.75 1.03 27.17
Dec 0.87 0.64 1.10 41.85

Biofrontera (BFRI) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.82 0.63 1.05 39.53
Feb 0.75 0.54 0.95 43.18
Mar 0.47 0.31 0.58 45.93
Apr 0.46 0.37 0.61 39.92
May 0.49 0.35 0.56 36.52
Jun 0.59 0.53 0.70 24.02
Jul 0.78 0.66 1.04 36.18
Aug 0.87 0.79 1.03 23.48
Sep 0.58 0.51 0.67 22.62
Oct 0.36 0.26 0.43 39.35
Nov 0.42 0.30 0.52 42.94
Dec 0.54 0.45 0.71 37.25

Biofrontera information and performance

Biofrontera Address

120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, US

Market Capitalization: 7 542 800 $

Market capitalization of the Biofrontera Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BFRI shares in the company outstanding by the market price of one share.

EBITDA: -16 789 000 $

EBITDA of Biofrontera is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.22

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.185
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.176

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.792

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 8873900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Biofrontera Stock)

Should I Buy Biofrontera Shares in 2025 year?

The maximum forecasted share price for next year is $0.88, which is $0.05 higher than the current stock price. By investing in Biofrontera shares today for a one-year period, you could achieve a profit of 6.15%. With an investment horizon of up to two years, the target share price is $0.87. resulting in a profit of 4.97% ($0.04 per share).

Does Biofrontera pay dividends?

No, it does not

Which economic sector do Biofrontera's shares belong to?

Biofrontera's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Biofrontera's shares?

You can view all the stocks that are part of the same sector as Biofrontera's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.